- Home
- IOSP vs TARS Comparison
IOSP vs TARS Comparison
Compare IOSP & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOSP
- TARS
- Stock Information
- Founded
- IOSP 1938
- TARS 2016
- Country
- IOSP United States
- TARS United States
- Employees
- IOSP N/A
- TARS N/A
- Industry
- IOSP Major Chemicals
- TARS Medicinal Chemicals and Botanical Products
- Sector
- IOSP Industrials
- TARS Health Care
- Exchange
- IOSP Nasdaq
- TARS Nasdaq
- Market Cap
- IOSP 2.0B
- TARS 1.7B
- IPO Year
- IOSP 1998
- TARS 2020
- Fundamental
- Price
- IOSP $76.95
- TARS $41.36
- Analyst Decision
- IOSP Strong Buy
- TARS Strong Buy
- Analyst Count
- IOSP 1
- TARS 7
- Target Price
- IOSP $155.00
- TARS $67.14
- AVG Volume (30 Days)
- IOSP 187.2K
- TARS 573.0K
- Earning Date
- IOSP 08-05-2025
- TARS 08-06-2025
- Dividend Yield
- IOSP 1.96%
- TARS N/A
- EPS Growth
- IOSP N/A
- TARS N/A
- EPS
- IOSP 1.08
- TARS N/A
- Revenue
- IOSP $1,786,000,000.00
- TARS $233,674,000.00
- Revenue This Year
- IOSP $0.74
- TARS $122.94
- Revenue Next Year
- IOSP $7.75
- TARS $44.14
- P/E Ratio
- IOSP $74.70
- TARS N/A
- Revenue Growth
- IOSP N/A
- TARS 449.03
- 52 Week Low
- IOSP $77.58
- TARS $20.08
- 52 Week High
- IOSP $128.35
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- IOSP 36.76
- TARS 49.58
- Support Level
- IOSP $77.58
- TARS $38.51
- Resistance Level
- IOSP $86.01
- TARS $42.11
- Average True Range (ATR)
- IOSP 1.68
- TARS 1.74
- MACD
- IOSP -0.44
- TARS -0.00
- Stochastic Oscillator
- IOSP 23.78
- TARS 37.88
About IOSP Innospec Inc.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Fuel Specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field service providers in the extraction of oil and gas. The Performance Chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.